Fagerholm P, Björklund H, Holmberg A, Larsson R, Lydahl E, Philipson B, Selén G
Department of Ophthalmology, Karolinska Institute, Stockholm, Sweden.
J Cataract Refract Surg. 1989 Sep;15(5):485-90. doi: 10.1016/s0886-3350(89)80103-8.
The biocompatibility of heparin surface modified poly(methyl methacrylate) intraocular lenses (IOLs) was evaluated in two experiments following implantation in the anterior and posterior eye chambers of adult cynomolgus monkeys. Throughout the study, large inflammatory cells and prominent pigment deposits were seen on the unmodified lenses, whereas the heparin surface modified IOLs remained almost free of precipitates. Similarly, fewer posterior synechias were observed in eyes implanted with surface modified IOLs in the posterior chamber than in eyes implanted with control lenses. Histopathological examination of enucleated eyes confirmed the clinical findings. These experiments strongly support the idea that surface modification with heparin is a useful way to reduce clinical complications following cataract surgery with IOL implantation.
在将肝素表面改性的聚甲基丙烯酸甲酯人工晶状体(IOL)植入成年食蟹猴的前房和后房后的两项实验中,对其生物相容性进行了评估。在整个研究过程中,未改性的晶状体上可见大量炎性细胞和明显的色素沉着,而肝素表面改性的IOL几乎没有沉淀物。同样,后房植入表面改性IOL的眼睛比植入对照晶状体的眼睛观察到的后粘连更少。摘除眼球的组织病理学检查证实了临床发现。这些实验有力地支持了这样一种观点,即肝素表面改性是减少白内障手术联合IOL植入后临床并发症的一种有效方法。